Azelis | AI Transformation Index
Azelis is a physically-anchored specialty chemicals distributor where AI's impact is real but structurally bounded — the logistics infrastructure and globa...
Overview
Azelis is a global specialty chemicals and food ingredients distributor that earns margin by sourcing from chemical manufacturers, providing technical application support, regulatory compliance guidance, and supply chain services to industrial customers across multiple end markets.
Executive Summary
Azelis is a physically-anchored specialty chemicals distributor where AI's impact is real but structurally bounded — the logistics infrastructure and global supplier network are AI-resilient, while the technical advisory layer (where Azelis earns its premium over commodity distributors) faces meaningful but not existential pressure from AI commoditizing formulation and compliance guidance. The primary AI opportunity is using LLMs to scale technical support and regulatory knowledge across more customers with less headcount, potentially opening SMB segments and deepening the value-added moat — but Azelis is not a high-urgency AI transformation target because the physical distribution core cannot be AI-transformed, limiting the magnitude of the step-change available. The key strategic risk is the advisory premium eroding if competitors or producers deploy AI to replicate Azelis's knowledge services faster than Azelis can reinvest that expertise into AI-augmented offerings.
Durability
How resilient is this business against AI disruption?
Market Substitutability
Profit Pool Migration
Barrier to Entry
Disintermediation Exposure
Switching Costs
Opportunity
How big a deal is AI for this business?
AI Applicability
Improvement Magnitude
Transformation Upside
Domain Intelligence Amplification
56.7
Ciridae AI Score
Durability Rationale
Azelis's durability rests on its irreplaceable physical distribution infrastructure — warehousing, hazmat logistics, and global supplier relationships across 60+ countries — which no AI-native entrant can replicate with software alone. The structural protection from regulatory certification requirements and capex barriers provides a meaningful floor. The key fragility is the value-added advisory layer (technical support, regulatory guidance) that justifies the distributor's premium margin; if AI commoditizes formulation advice and compliance guidance, Azelis risks becoming a lower-margin pure logistics play with more direct competition from physical-only distributors, while also facing the long-run disintermediation risk of large producers building AI-assisted direct sales capabilities.
Opportunity Rationale
The AI opportunity for Azelis is moderate and concentrated in specific cognitive workflows rather than a whole-business transformation — the physical distribution core limits how much of the business AI can actually touch. Where AI matters most is in scaling formulation advisory and regulatory compliance support without proportional headcount growth, potentially allowing Azelis to serve smaller customers economically and deepen its value-added differentiation. The most interesting angle is amplifying Azelis's accumulated domain intelligence — years of cross-industry formulation applications, supplier performance data, and regulatory precedent — into a more systematized recommendation and compliance engine; but this is an enhancement to an existing physical business, not a step-change transformation.
Key Risks
The durability assessment could be wrong if large chemical producers (BASF, Dow, Evonik) aggressively build AI-assisted direct sales platforms that replicate formulation advisory at scale, accelerating disintermediation faster than Azelis's physical moat can offset — particularly for mid-sized customers where Azelis earns the most margin.
The opportunity assessment could be wrong if Azelis's domain intelligence is less proprietary than assumed — if most formulation and regulatory knowledge is codifiable from public technical data, a general-purpose LLM could replicate the advisory layer without Azelis-specific training data, making the amplification opportunity smaller and the disruption risk larger simultaneously.
Company Overview
| Headquarters | Merelbeke, Belgium |
| Products / Services | Specialty chemicals and food ingredients distribution, innovation services including application laboratories, sampling and evaluation, REACH compliance management, and international supply chain services |
| Deal Partners |
PE / Ownership History
| Event | Details |
|---|---|
EQT agreed to sale of shares in Azelis Group NV November 12, 2025 | EQT agreed to sell approximately 44 million shares in Azelis Group NV to existing shareholders. Following this sale, EQT retained about a 10% ownership stake in Azelis, with the remaining shares subject to a 90-day lock-up period. The sale generated aggregate gross proceeds of approximately EUR 366 million, with EQT receiving about EUR 333 million. |
Acquired by EQT VIII and PSP Investments November 8, 2018 | EQT VIII, in partnership with PSP Investments, acquired Azelis from funds advised by Apax Partners. The transaction closed on November 8, 2018. Financial terms were not disclosed publicly. Azelis had around 1,800 employees and sales of approximately €1.8 billion at the time of acquisition. Simon Marc, Managing Director and Head of Private Equity at PSP Investments, was also a key figure backing the acquisition. |
Executives
| Name | Background |
|---|---|
Anna Bertona Group Chief Executive Officer (CEO) | Over 30 years of experience in consumer goods, automotive, and strategy consultancy. Former partner at A.T. Kearney, focusing on chemical industry strategy, sales excellence, growth, performance improvements, and post-merger integration. Holds a master's in Industrial Design Engineering from Delft University of Technology and an MBA from Rotterdam School of Management. Serves as a non-executive board member at Solabia. |
Boris Cambon-Lalanne Chief Financial Officer (CFO) | Over 20 years of financial expertise in the chemical industry. Held senior roles at Rhodia and Solvay, most recently as Capital Markets Director. Known for building high-performing cross-cultural teams and driving sustainability initiatives. |
Evy Hellinckx Chief Executive Officer, EMEA | Joined Azelis in 2016 as Strategy and Business Development Director for EMEA. Former Managing Director of Azelis Benelux, significantly growing the company's footprint. Prior experience includes Johnson & Johnson medical devices division and strategic consulting at Bain & Company. |
Todd Cottrell Chief Executive Officer, Americas | Over 30 years leading global chemicals and materials businesses in aerospace, coatings, sealants, adhesives, and composites. Previous leadership roles at Hempel A/S, Birla Carbon, Huntsman, Kraton Polymers, and PPG. Holds a BS in Chemical Engineering from Michigan Technological University and an MBA from Fuqua College of Business at Duke University. |
Benoit Fritz Chief Executive Officer, Asia Pacific | Over 25 years of experience in global companies including Safic-Alcan, DuPont-Dow Elastomers, and Dow Wire & Cable. Holds a Master of Advanced Studies from École Normale Supérieure and a Master of Science from Pierre and Marie Curie University in organic and bio-organic chemistry. |

EQT